Lee Ainslie Seer, Inc. Transaction History

Maverick Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.7 - $13.31 $7.75 Million - $13.4 Million	-1,006,864 Reduced 46.39%	1,163,792 $9.01 Million
Q2 2022 Aug 15, 2022	SELL	$6.72 - $16.07 $7.55 Million - $18 Million	-1,122,783 Reduced 34.09%	2,170,656 $19.4 Million
Q1 2022 May 16, 2022	BUY	$11.88 - $23.4 $1.94 Million - $3.83 Million	163,550 Added 5.23%	3,293,439 $50.2 Million
Q4 2021 Feb 14, 2022	SELL	$21.08 - $38.51 $48.3 Million - $88.1 Million	-2,289,004 Reduced 42.24%	3,129,889 $71.4 Million
Q2 2021 Aug 16, 2021	SELL	$28.75 - $56.92 $27,312 - $54,074	-950 Reduced 0.02%	5,418,893 $178 Million
Q1 2021 May 17, 2021	SELL	$38.67 - $84.06 $219,258 - $476,620	-5,670 Reduced 0.1%	5,419,843 $262 Million
Q4 2020 Feb 16, 2021	BUY	$55.23 - $81.11 $300 Million - $440 Million	5,425,513 New	5,425,513 $279 Million

35.1M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $132M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.